Author: OneMedPlace Team
Our Sentinel this week features the second installment of our series on bioinformatics. Bioinformatics has become an essential catalyst to better understanding gene therapy, as well as a unique investment opportunity.
In addition, OneMedRadio spoke with Cyto Wave Therapeutics head George Yu, discussing in vivo testing for CTCs. Lastly, don’t miss our feature exploring the state of influenza, and alternatives to traditional vaccination being developed by NanoViricides (NNVC).
Enjoy this issue.